ATTENUKINE
Live / Applied — Fifth extension granted (statement of use) (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 06 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97205484
- Mark type
- Stylized text
- Filed
- 06 Jan 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and autoimmune diseases
Owner
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
Prosecution history
- 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 5 GRANTED
- 20 Jan 2026 — SOU EXTENSION 5 FILED
- 11 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 24 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 24 Feb 2026 — PETITION TO REVIVE-GRANTED
- 24 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 23 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 04 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED